- Home
- CAPT vs KZR Comparison
CAPT vs KZR Comparison
Compare CAPT & KZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAPT
- KZR
- Stock Information
- Founded
- CAPT 2005
- KZR 2015
- Country
- CAPT South Korea
- KZR United States
- Employees
- CAPT N/A
- KZR N/A
- Industry
- CAPT Blank Checks
- KZR Biotechnology: Pharmaceutical Preparations
- Sector
- CAPT Finance
- KZR Health Care
- Exchange
- CAPT Nasdaq
- KZR Nasdaq
- Market Cap
- CAPT 31.2M
- KZR 29.7M
- IPO Year
- CAPT N/A
- KZR 2018
- Fundamental
- Price
- CAPT $0.83
- KZR $6.28
- Analyst Decision
- CAPT
- KZR Hold
- Analyst Count
- CAPT 0
- KZR 4
- Target Price
- CAPT N/A
- KZR $6.00
- AVG Volume (30 Days)
- CAPT 154.6K
- KZR 433.0K
- Earning Date
- CAPT 01-01-0001
- KZR 11-11-2025
- Dividend Yield
- CAPT N/A
- KZR N/A
- EPS Growth
- CAPT N/A
- KZR N/A
- EPS
- CAPT N/A
- KZR N/A
- Revenue
- CAPT $17,389,944.00
- KZR N/A
- Revenue This Year
- CAPT N/A
- KZR N/A
- Revenue Next Year
- CAPT N/A
- KZR N/A
- P/E Ratio
- CAPT N/A
- KZR N/A
- Revenue Growth
- CAPT 84.70
- KZR N/A
- 52 Week Low
- CAPT $0.37
- KZR $3.53
- 52 Week High
- CAPT $1.94
- KZR $8.60
- Technical
- Relative Strength Index (RSI)
- CAPT 39.02
- KZR 83.18
- Support Level
- CAPT $0.82
- KZR $4.10
- Resistance Level
- CAPT $0.86
- KZR $4.45
- Average True Range (ATR)
- CAPT 0.05
- KZR 0.31
- MACD
- CAPT 0.00
- KZR 0.27
- Stochastic Oscillator
- CAPT 10.25
- KZR 96.56
About CAPT Captivision Inc.
Captivision Inc Formerly Glaam Co Ltd is engaged in manufacturing, installing, and selling LED display G-Glass. G-Glass is an integrated ICT product that has the basic characteristics of transparent glass but can display media images at the same time. It implements media images through the glass surface while preserving the features of clear and transparent glass. G-Glass is the world's first IT building material that can be applied to various places where glass is used.
About KZR Kezar Life Sciences Inc.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.